According to Protos, Nasdaq-listed Enlivex (originally engaged in arthritis biotherapy research) saw its stock price plummet to an all-time low of $0.42 after pivoting to a "Prediction Market Digital Asset Treasury (DAT)" strategy, down 30% year-to-date and 94% over the past five years. The company previously raised $200 million through private placements and restructured its balance sheet with a heavy focus on the RAIN token, currently holding 12% of its circulating supply. On-chain detective ZachXBT pointed out that the RAIN token is linked to Israeli entrepreneur Moshe Hogeg, who is facing a $290 million enforcement investigation. Although the RAIN tokens held by Enlivex are valued at $1.2 billion on its books, its own market cap is only $118 million, and some assets are subject to staking or other serious liability issues.